Brief Report: Maternal Opioid Prescription from Preconception Through Pregnancy and the Odds of Autism Spectrum Disorder and Autism Features in Children

Eric Rubenstein, Jessica C. Young, Lisa A. Croen, Carolyn DiGuiseppi, Nicole F. Dowling, Li-Ching Lee, Laura Schieve, Lisa D. Wiggins, Julie Daniels

Research output: Contribution to journalArticle

Abstract

Opioid use during pregnancy is associated with suboptimal pregnancy outcomes. Little is known about child neurodevelopmental outcomes. We examined associations between maternal opioid prescriptions preconception to delivery (peri-pregnancy) and child’s risk of ASD, developmental delay/disorder (DD) with no ASD features, or ASD/DD with autism features in the Study to Explore Early Development, a case-control study of neurodevelopment. Preconception opioid prescription was associated with 2.43 times the odds of ASD [95% confidence interval (CI) 0.99, 6.02] and 2.64 times the odds of ASD/DD with autism features (95% CI 1.10, 6.31) compared to mothers without prescriptions. Odds for ASD and ASD/DD were non-significantly elevated for first trimester prescriptions. Work exploring mechanisms and timing between peri-pregnancy opioid use and child neurodevelopment is needed.

Original languageEnglish (US)
JournalJournal of Autism and Developmental Disorders
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Autistic Disorder
Opioid Analgesics
Prescriptions
Mothers
Pregnancy
Confidence Intervals
Developmental Disabilities
First Pregnancy Trimester
Pregnancy Outcome
Case-Control Studies
Autism Spectrum Disorder

Keywords

  • ASD
  • Developmental disorder
  • Opioid
  • Pregnancy
  • Risk factor

ASJC Scopus subject areas

  • Developmental and Educational Psychology

Cite this

Brief Report : Maternal Opioid Prescription from Preconception Through Pregnancy and the Odds of Autism Spectrum Disorder and Autism Features in Children. / Rubenstein, Eric; Young, Jessica C.; Croen, Lisa A.; DiGuiseppi, Carolyn; Dowling, Nicole F.; Lee, Li-Ching; Schieve, Laura; Wiggins, Lisa D.; Daniels, Julie.

In: Journal of Autism and Developmental Disorders, 01.01.2018.

Research output: Contribution to journalArticle

Rubenstein, Eric ; Young, Jessica C. ; Croen, Lisa A. ; DiGuiseppi, Carolyn ; Dowling, Nicole F. ; Lee, Li-Ching ; Schieve, Laura ; Wiggins, Lisa D. ; Daniels, Julie. / Brief Report : Maternal Opioid Prescription from Preconception Through Pregnancy and the Odds of Autism Spectrum Disorder and Autism Features in Children. In: Journal of Autism and Developmental Disorders. 2018.
@article{4f474a6c14bf4eea8861fb629d4b895f,
title = "Brief Report: Maternal Opioid Prescription from Preconception Through Pregnancy and the Odds of Autism Spectrum Disorder and Autism Features in Children",
abstract = "Opioid use during pregnancy is associated with suboptimal pregnancy outcomes. Little is known about child neurodevelopmental outcomes. We examined associations between maternal opioid prescriptions preconception to delivery (peri-pregnancy) and child’s risk of ASD, developmental delay/disorder (DD) with no ASD features, or ASD/DD with autism features in the Study to Explore Early Development, a case-control study of neurodevelopment. Preconception opioid prescription was associated with 2.43 times the odds of ASD [95{\%} confidence interval (CI) 0.99, 6.02] and 2.64 times the odds of ASD/DD with autism features (95{\%} CI 1.10, 6.31) compared to mothers without prescriptions. Odds for ASD and ASD/DD were non-significantly elevated for first trimester prescriptions. Work exploring mechanisms and timing between peri-pregnancy opioid use and child neurodevelopment is needed.",
keywords = "ASD, Developmental disorder, Opioid, Pregnancy, Risk factor",
author = "Eric Rubenstein and Young, {Jessica C.} and Croen, {Lisa A.} and Carolyn DiGuiseppi and Dowling, {Nicole F.} and Li-Ching Lee and Laura Schieve and Wiggins, {Lisa D.} and Julie Daniels",
year = "2018",
month = "1",
day = "1",
doi = "10.1007/s10803-018-3721-8",
language = "English (US)",
journal = "Journal of Autism and Developmental Disorders",
issn = "0162-3257",
publisher = "Springer New York",

}

TY - JOUR

T1 - Brief Report

T2 - Maternal Opioid Prescription from Preconception Through Pregnancy and the Odds of Autism Spectrum Disorder and Autism Features in Children

AU - Rubenstein, Eric

AU - Young, Jessica C.

AU - Croen, Lisa A.

AU - DiGuiseppi, Carolyn

AU - Dowling, Nicole F.

AU - Lee, Li-Ching

AU - Schieve, Laura

AU - Wiggins, Lisa D.

AU - Daniels, Julie

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Opioid use during pregnancy is associated with suboptimal pregnancy outcomes. Little is known about child neurodevelopmental outcomes. We examined associations between maternal opioid prescriptions preconception to delivery (peri-pregnancy) and child’s risk of ASD, developmental delay/disorder (DD) with no ASD features, or ASD/DD with autism features in the Study to Explore Early Development, a case-control study of neurodevelopment. Preconception opioid prescription was associated with 2.43 times the odds of ASD [95% confidence interval (CI) 0.99, 6.02] and 2.64 times the odds of ASD/DD with autism features (95% CI 1.10, 6.31) compared to mothers without prescriptions. Odds for ASD and ASD/DD were non-significantly elevated for first trimester prescriptions. Work exploring mechanisms and timing between peri-pregnancy opioid use and child neurodevelopment is needed.

AB - Opioid use during pregnancy is associated with suboptimal pregnancy outcomes. Little is known about child neurodevelopmental outcomes. We examined associations between maternal opioid prescriptions preconception to delivery (peri-pregnancy) and child’s risk of ASD, developmental delay/disorder (DD) with no ASD features, or ASD/DD with autism features in the Study to Explore Early Development, a case-control study of neurodevelopment. Preconception opioid prescription was associated with 2.43 times the odds of ASD [95% confidence interval (CI) 0.99, 6.02] and 2.64 times the odds of ASD/DD with autism features (95% CI 1.10, 6.31) compared to mothers without prescriptions. Odds for ASD and ASD/DD were non-significantly elevated for first trimester prescriptions. Work exploring mechanisms and timing between peri-pregnancy opioid use and child neurodevelopment is needed.

KW - ASD

KW - Developmental disorder

KW - Opioid

KW - Pregnancy

KW - Risk factor

UR - http://www.scopus.com/inward/record.url?scp=85052607089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052607089&partnerID=8YFLogxK

U2 - 10.1007/s10803-018-3721-8

DO - 10.1007/s10803-018-3721-8

M3 - Article

JO - Journal of Autism and Developmental Disorders

JF - Journal of Autism and Developmental Disorders

SN - 0162-3257

ER -